Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver that most commonly presents late in the disease course. As a result, the majority of patients are not candidates for curative therapies. Locoregional therapies including Yttrium-90 (Y-90) radioembolization play...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Bhangoo, Munveer Singh, Karnani, Diraj R., Hein, Paul N., Giap, Huan, Knowles, Harry, Issa, Chris, Steuterman, Steve, Pockros, Paul, Frenette, Catherine
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2015
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570909/
https://ncbi.nlm.nih.gov/pubmed/26487939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2015.056
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares